Clean Energy Stocks Defy Trump's Climate Denial
Despite Trump's anti-climate rhetoric, renewable energy stocks are showing surprising resilience. Discover why market forces are overpowering political denial in the clean tech revolution.
Category : Search result: European pharma stocks
Thangamayil Jewellery Stock Jumps 70% in 10 Sessions
Discover how Thangamayil Jewellery shares skyrocketed 70% despite market weakness, with strong Q4 results driving investor frenzy. Is this multibagger in your portfolio?
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
European Film Festival in Bengaluru from Nov 7
Bengaluru gears up for the much-awaited European Film Festival featuring 24 award-winning movies from 24 countries at Goethe-Institut. Don't miss this cultural extravaganza!
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
8 Hidden European Food Gems You Must Try
Move beyond pizza and pasta! Discover Europe's best-kept culinary secrets - from Portugal's surprising sandwich to Poland's secret soup that will transform your food journey.
Tech Sector Reset: Nvidia Earnings Critical for Recovery
As global tech stocks face a major correction, all eyes turn to Nvidia's upcoming earnings report. Discover how the AI chip giant's performance could determine the sector's future trajectory amid rising Treasury yields and valuation concerns.
8 Hidden European Dishes You Must Try
Explore Europe's best-kept culinary secrets! From Portugal's Francesinha to Poland's Żurek, discover 8 underrated dishes that will transform your food journey.
India Mining Boom: 5 Stocks to Watch
Discover how India's mining sector revival is creating unprecedented opportunities in small-cap stocks. Our expert analysis reveals five hidden gems poised for massive growth as government reforms and infrastructure spending accelerate.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
EU Waters Down 2040 Climate Target Before COP30
The European Union has finalized a compromised 2040 climate target, raising concerns among environmentalists as crucial COP30 talks approach. Discover how political pressures are shaping Europe's green transition.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Multibagger Stock Soars 1,100% in One Year
Discover how Waaree Renewables Technologies delivered staggering 1,100% returns in just 12 months, hitting upper circuits repeatedly. Learn what's driving this solar energy stock's phenomenal performance.
Blue Cloud Softech Jumps 4% on Business Wins
Small-cap IT player Blue Cloud Softech Solutions surges 4% after securing significant new business contracts. Discover why this sub-₹50 stock is catching investor attention with its latest expansion moves.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Dividend Stocks: Coal India, Mazagon Dock, BPCL Go Ex-Dividend
Indian investors set for dividend windfall as major PSUs including Coal India, Mazagon Dock, and BPCL trade ex-dividend next week. Complete list of companies and key dates revealed.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
European nation tells Ukraine: Stop making demands
A major European nation delivers blunt message to Kyiv as support wanes. Zelensky's approach faces criticism while global powers reassess Ukraine strategy. Exclusive details inside.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Hoteliers Ltd Stock Soars 1000% in 1 Year
Discover how Hoteliers Ltd became India's top-performing hospitality stock with an incredible 1000% surge despite broader market weakness. Learn what's driving this exceptional rally.
Europe's Ukraine Funding: Strategic Opportunity Revealed
European leaders are discovering that supporting Ukraine isn't just about defense - it's a strategic economic opportunity that could reshape Europe's future and boost its military-industrial complex.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
FIIs Bet Big on Midcap Stocks: Ashapura, Skipper, PCBL Surge
Foreign Institutional Investors are aggressively accumulating midcap stocks in India. Discover which chemical, infrastructure, and specialty companies are attracting massive FII interest and driving market momentum.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Page 3 of 4